AI assistant
Sending…
Anixa Biosciences Inc — Director's Dealing 2011
May 27, 2011
34117_dirs_2011-05-27_5cabc70e-ed70-4e53-b0da-4d6ecf7e4803.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2011-05-25
Reporting Person: LAROUNIS GEORGE P (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-05-25 | Common Stock | M | 60000 | $0.20 | Acquired | 380000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-05-25 | Employee Stock Option | $0.20 | M | 60000 | Disposed | 2015-10-25 | Common Stock (60000) | Direct |
Footnotes
F1: Right-To-Buy, pursuant to the Copytele, Inc. 2010 Share Incentive Plan.
F2: Option was amended to change the date that the option is first exerciasable from October 26, 2011 to May 25, 2011
More from Anixa Biosciences Inc
Regulatory Filings
2026
Mar 11
Interim / Quarterly Report
2026
Mar 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 29
Proxy Solicitation & Information Statement
2026
Jan 28
Regulatory Filings
2026
Jan 12
Annual Report
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6